Movira, Reymond J.
HRN: 23-14-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/19/2024
06/26/2024
IV
4.5 G
Every 8 Hours
Gut Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes